Nasdaq

InMode Introduces the Morpheus8 Platform and the Morpheus8 Body Fractional Technology

LAKE FOREST, Calif., Aug. 13, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to announce a new FDA clearance to ...
Nasdaq

InMode Introduces Morpheus8 Body Multi-pulse Burst Technology

LAKE FOREST, Calif., Oct. 20, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to introduce to the market the ...
Seeking Alpha

InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges

IRVINE, Calif., May 6, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, reports that the US District Court for the Central District of ...
Seeking Alpha

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

IRVINE, Calif., Oct. 24, 2024 /PRNewswire/ -- InMode Ltd. (INMD), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S. District Court for ...
Healio

FDA clears first fractional radiofrequency microneedling tool for soft tissue contraction

Please provide your email address to receive an email when new articles are posted on . The FDA cleared Morpheus8 for contraction of soft tissue. This is the first and only fractional radiofrequency ...